ANALYSIS: Financing slumps as summer ends
This article was originally published in Clinica
The higher you go, the harder the fall. While July’s medtech venture financing takings reached heady heights, thanks to ConforMIS’s record-busting $168m series E (www.clinica.co.uk, 2 August 2013), August saw VC deal flow dry up to a mere trickle.
You may also be interested in...
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.
Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.